ArticleScientific reports2026
Respiratory sound-based AI screening of asthma and COPD via multi-feature fusion and CatBoost classification.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asthma and chronic obstructive pulmonary disease (COPD) are significant global health burdens with conventional diagnosis relying on resource-intensive spirometry. This paper presents a reproducible multimodal respiratory sound screening model combining complementary acoustic and clinical representations. The proposed method fuses handcrafted spectral-temporal features (MFCCs, chroma, spectral contrast, tonnetz, mel-spectrogram, tempogram) with precomputed cough and vowel embeddings and structured clinical metadata, processed via a class-weighted CatBoost ensemble on the standardized AIRS Kaggle benchmark dataset. The model achieves an overall accuracy of 90.3% with class-wise F1-scores of 0.945 (Healthy), 0.915 (Asthma), and 0.842 (COPD). Systematic ablation experiments confirm the importance of multimodal fusion (-7.8% accuracy without full feature fusion), the attention mechanism (-4.9%), and data augmentation (-6.7%). Additional metrics such as, Matthews Correlation Coefficient (MCC = 0.856) and Cohen's Kappa (κ = 0.849) - confirm robust classification under class imbalance. Structured multimodal feature fusion with gradient boosting enables scalable, reproducible respiratory disease screening applicable to telemedicine. Future work should address prospective validation on diverse, multi-institutional clinical cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.